Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 06/09/20 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 06/09/20 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 06/09/20 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 06/09/20 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 06/09/20 | Current report filing |
|
3 | ||
| 05/28/20 | Current report filing |
|
44 | ||
| 05/19/20 | Notice of Effectiveness |
|
1 | ||
| 05/19/20 | Prospectus filed pursuant to Rule 424(b)(3) |
|
22 | ||
| 05/15/20 | Quarterly report pursuant to Section 13 or 15(d) |
|
 |
89 | |
| 05/15/20 | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
2 |